A Clinical Study of SPH7854 Granules in Healthy Subjects.
NCT06483373 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 111
Last updated 2026-05-05
Summary
To evaluate the safety of SPH7854 in healthy subjects.
Conditions
Interventions
- DRUG
-
SPH7854
SPH7854： Orally, 50-3200mg
- DRUG
-
Placebo：Orally；
Sponsors & Collaborators
-
Shanghai Pharmaceuticals Holding Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-28
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
A Single and Multiple-Dose Study of SB1578
NCT01235871 ·Status: COMPLETED ·Phase: PHASE1
-
The PK/PD Study of SHR7280 Tablets in Healthy Subjects.
NCT04554043 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of XH-S003 in Healthy Volunteers
NCT05946876 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects
NCT03956953 ·Status: COMPLETED ·Phase: PHASE1
-
PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers
NCT02603185 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
NCT06995001 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants
NCT06682975 ·Status: RECRUITING ·Phase: PHASE1
-
A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS
NCT02749097 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of SHR -2001 in Healthy Subjects
NCT05942612 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers
NCT05421923 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects
NCT03372629 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
NCT06022354 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)
NCT06829225 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
NCT06086886 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers
NCT04238364 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375
NCT05026008 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study(Additional) of URC102 in Healthy Subjects
NCT02524678 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SGB-9768 in Adult Healthy Volunteers
NCT06501573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase I Study of XH-S004 in Healthy Volunteers
NCT06236841 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
NCT02327273 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose Ethnobridging PK Study in Healthy Subjects
NCT03750565 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Experimental Medication BMS-986235 in Healthy Subjects
NCT03335553 ·Status: COMPLETED ·Phase: PHASE1
-
First-into-human Study of NS-136 in Healthy Subjects
NCT06345703 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of STSA-1201 in Healthy Subjects
NCT05986877 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants
NCT04676685 ·Status: COMPLETED ·Phase: PHASE1